IMVAQ THERAPEUTICS
Imvaq Therapeutics is an innovative cancer immunotherapy company.
IMVAQ THERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Sammamish, Washington, United States
Country:
United States
Website Url:
http://www.imvaq.com
Total Employee:
1+
Status:
Active
Total Funding:
20 M USD
Technology used in webpage:
PHP OpenResty Network Solutions DNS Network Solutions Network Solutions Email Hosting
Similar Organizations
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Hanne Capital
Hanne Capital investment in Series B - IMVAQ Therapeutics
Official Site Inspections
http://www.imvaq.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.238
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "IMVAQ Therapeutics"
About Us - Imvax
Prior to Spark, Mr. Furey served as Senior Vice President and Head of Global Operations at Baxalta, where he transformed the company’s global operations into a first-in-class supply …See details»
Imvax » Turning the complexity of solid tumors against …
Harnessing decades of research and multiple validated technologies, Imvax’s unique platform captures a tumor’s full antigen signature and uses it to stimulate the patient’s innate and adaptive immunity against remaining tumor cells. …See details»
Life at Imvax - Imvax
Imvax is committed to creating an inclusive community where every individual is treated with dignity and respect. Fostering a culture in which we celebrate and embrace every team …See details»
Imvax - Crunchbase Company Profile & Funding
Organization. Imvax . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Imvax is a biotechnology company focused on the development of novel patient-specific …See details»
Imvax, Inc. - LinkedIn
Imvax, Inc. | 2,705 followers on LinkedIn. Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. | Imvax is a clinical-stage …See details»
Imvax Company Profile 2025: Valuation, Funding
Imvax is headquartered in Philadelphia, PA. What is the size of Imvax? Imvax has 48 total employees. What industry is Imvax in? Imvax’s primary industry is Drug Discovery. Is Imvax a private or public company? Imvax is a Private company. …See details»
Imvax - Funding, Financials, Valuation & Investors - Crunchbase
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies. Search Crunchbase. ... How much funding has this …See details»
Imvax - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Imvax . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Imvax Company Profile - Office Locations, Competitors, Revenue
Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers. It produces IGV-001, an autologous tumor …See details»
Imvax - Company Profile - Tracxn
Aug 17, 2021 Imvax ranks 2nd among 47 active competitors. 21 of its competitors are funded while 7 have exited. Overall, Imvax and its competitors have raised over $462M in funding …See details»
Culture & Careers - Imvax
Imvax is committed to creating an inclusive community where every individual is treated with dignity and respect. Fostering a culture in which we celebrate and embrace every team …See details»
Imvax Company Profile: Overview and Full News Analysis
Imvax, Inc. will present blinded safety data from Phase 2b clinical trial of IGV-001 in patients with newly diagnosed glioblastoma (ndGBM) The Company will also present follow-on data from its …See details»
The Transformative Potential of Immunotherapy for Glioblastoma …
Nov 25, 2023 As a corporate partner of the Glioblastoma Research Organization, Imvax demonstrates its commitment to advancing brain cancer research and supporting GBM …See details»
Imvax - Crunchbase
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies. ... Products. Resources. Pricing. Resources. Log In. …See details»
ImVax, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Imvax will present blinded safety data from the Company’s ongoing randomized, multicenter, double-blind, placebo-controlled Phase 2b clinical trial of IGV-001 in patients with newly …See details»
Imvax: Personalized Immunotherapy for Glioblastoma Patients
Imvax attends the ABTA National Conference, the largest brain tumor conference in the U.S., providing support to patients, caregivers, and survivors. Additionally, Imvax sponsors and …See details»
Imvax Appoints Sean Hemingway as Chief Operating Officer
Imvaxâ„¢ is an emerging oncology leader that is revolutionizing immunotherapy for patients with Glioblastoma (GBM) and other solid tumors with significant unmet medical needs. Its lead …See details»
Phase 2b of a Promising Brain Tumor Clinical Trial Begins
Aug 9, 2023 Imvax’s most advanced program, IGV-001, is currently being evaluated in a Phase 2b clinical trial in newly diagnosed glioblastoma patients. Imvax’s portfolio includes also …See details»
Imvax Advances a New Approach to Personalized Cancer …
Imvax is a clinical-stage biotechnology company headquartered in Philadelphia, PA, with a unique platform technology, Goldspireâ„¢. Goldspire harnesses decades of research and multiple …See details»
Patients & Families - Imvax
What Phase 1 studies has Imvax conducted? To date, two Phase 1 clinical studies of IGV-001 in recurrent GBM and ndGBM have been completed that dosed a total of 46 patients. The larger …See details»